147 related articles for article (PubMed ID: 6443348)
1. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20).
van Hasselt M; Weiss M; Haase W
Curr Med Res Opin; 1984; 9(2):107-12. PubMed ID: 6443348
[TBL] [Abstract][Full Text] [Related]
2. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20): a multi-centre study in hospital and general practice.
Marten W; Weiss M; Haase W
Curr Med Res Opin; 1984; 9(2):96-106. PubMed ID: 6443349
[TBL] [Abstract][Full Text] [Related]
3. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC
Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056
[TBL] [Abstract][Full Text] [Related]
4. Isosorbide-5-mononitrate and isosorbide dinitrate retard in the treatment of coronary heart disease: a multi-centre study.
Bidoggia H
Curr Med Res Opin; 1987; 10(9):601-11. PubMed ID: 3325229
[TBL] [Abstract][Full Text] [Related]
5. An open, long-term, multi-centre study of the anti-anginal efficacy and safety of isosorbide 5-mononitrate at low doses in patients with coronary heart disease.
Uberbacher HJ; Steinorth G; Glocke M; Abshagen U
Pharmatherapeutica; 1983; 3(5):331-41. PubMed ID: 6342004
[TBL] [Abstract][Full Text] [Related]
6. Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.
Silber S
Eur J Clin Pharmacol; 1990; 38 Suppl 1():S35-51. PubMed ID: 2113003
[TBL] [Abstract][Full Text] [Related]
7. Optimal nitrate therapy with a once-daily sustained-release formulation of isosorbide mononitrate.
Waller DG
J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 2():S21-7; discussion S29-31. PubMed ID: 10499557
[TBL] [Abstract][Full Text] [Related]
8. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
Thadani U
Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
[TBL] [Abstract][Full Text] [Related]
9. Abrupt withdrawal of isosorbide-5-mononitrate in Durules (Imdur) after long term treatment in patients with stable angina pectoris.
Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Reinikainen P
Eur Heart J; 1988 Dec; 9(12):1339-47. PubMed ID: 3147892
[TBL] [Abstract][Full Text] [Related]
10. [The effect of time and dosage of isosorbide mononitrate on objective and subjective parameters in angina pectoris].
Herrmann H; Kuhl A; Maier-Lenz H
Arzneimittelforschung; 1988 May; 38(5):694-8. PubMed ID: 3415710
[TBL] [Abstract][Full Text] [Related]
11. [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
Martsevich SIu; Semenova IuE; Alimova EV; Dmitrieva nA; Kozyreva MP; Koniakhina IP; Lukina IuV; Egorov VA
Kardiologiia; 2005; 45(11):42-5. PubMed ID: 16353064
[TBL] [Abstract][Full Text] [Related]
12. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R; Johnen R; Vydra L; Solbach C
Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of coronary disease with elantan. Results of a multicenter study].
van Hasselt P; Weiss M; Haase W
Fortschr Med; 1984 Jan; 102(1-2):55-60. PubMed ID: 6365709
[TBL] [Abstract][Full Text] [Related]
14. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
Walker JM; Curry PV; Bailey AE; Steare SE
Int J Cardiol; 1996 Feb; 53(2):117-26. PubMed ID: 8682597
[TBL] [Abstract][Full Text] [Related]
15. Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate.
Quyyumi AA; Crake T; Wright CM; Mockus LJ; Fox KM
Br Heart J; 1987 Jun; 57(6):505-11. PubMed ID: 3304367
[TBL] [Abstract][Full Text] [Related]
16. Treatment of angina pectoris with isosorbide-5-mononitrate. A multicenter study in general practice.
Beck EJ; Koch JE
Cardiology; 1991; 79 Suppl 2():41-5. PubMed ID: 1760828
[TBL] [Abstract][Full Text] [Related]
17. Abrupt withdrawal of isosorbide 5-mononitrate (Imdur) after long term treatment in stable angina pectoris. A preliminary report.
Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Härkönen R
Drugs; 1987; 33 Suppl 4():118-21. PubMed ID: 2887419
[TBL] [Abstract][Full Text] [Related]
18. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of isosorbide dinitrates and mononitrates in patients with ischemic heart disease and stable angina pectoris caused by stenosing coronary atherosclerosis].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Chotchaev KhKh; Naumov VG
Klin Med (Mosk); 2000; 78(9):52-5. PubMed ID: 11051743
[TBL] [Abstract][Full Text] [Related]
20. A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina.
Akhras F; Chambers J; Jefferies S; Jackson G
Int J Cardiol; 1989 Aug; 24(2):191-6. PubMed ID: 2504673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
